Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction
Author(s) -
Davy Vanhoutte,
Mark W.M. Schellings,
Martin Götte,
Melissa Swinnen,
Veronica Hérias,
Martin K. Wild,
Dietmar Vestweber,
Emmanuel Chorianopoulos,
Vı́ctor Cortés,
Attilio Rigotti,
Mary Ann Stepp,
Frans Van de Werf,
Peter Carmeliet,
Yigal M. Pinto,
Stéphane Heymans
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.644609
Subject(s) - medicine , inflammation , myocardial infarction , wound healing , syndecan 1 , cardiac function curve , heart failure , cardiology , endocrinology , immunology , cell , biology , genetics
The cell-associated proteoglycan syndecan-1 (Synd1) closely regulates inflammation and cell-matrix interactions during wound healing and tumorigenesis. The present study investigated whether Synd1 may also regulate cardiac inflammation, matrix remodeling, and function after myocardial infarction (MI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom